Skip to main content

Inactivation of HIV and Safety Precautions for the Workplace

  • Conference paper
AIDS-Related Neoplasias

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 112))

Abstract

In June 1981 the initial reports of the occurrences of Pneumocystis carinii pneumonia and Kaposi’s sarcoma in previously healthy homosexual men [1, 2] heralded the beginning of the epidemic now known as the acquired immune deficiency syndrome (AIDS). Shortly thereafter it was recognized that the particular populations found to be at risk for the development of AIDS — homosexual or bisexual men, intravenous drug users, hemophiliacs, and people who have received blood transfusions or other blood products — were also known to be at risk for infection with hepatitis B (HBV).

This manuskript was supported by the Howard Gilman Foundation and the Samuel and May Rudin Foundation, both of New York.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gottlieb MS, Schroff R, Schanker HM et al. (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425

    Article  PubMed  CAS  Google Scholar 

  2. Friedman-Kien AE, Laubenstein L, Marmor M et al. (1981) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men – New York and California. MMWR 30: 250–252

    Google Scholar 

  3. Barre-Sinoussi F, Chermann JC, Rey F et al. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871

    Article  PubMed  CAS  Google Scholar 

  4. Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–500

    Article  PubMed  CAS  Google Scholar 

  5. Centers for Disease Control (1987) Recommendations for prevention of HIV transmission in health-care settings. MMWR 35 [Suppl 2S]: 3–18

    Google Scholar 

  6. Ward JW, Deppe DA, Samson S et al. (1987) Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med 106: 61–62

    PubMed  CAS  Google Scholar 

  7. Curran JW, Morgan MM, Hardy AM et al. (1985) The epidemiology of AIDS: current status and future prospects. Science 229: 1352–1357

    Article  PubMed  CAS  Google Scholar 

  8. Friedland CH, Klein RS (1987) Transmission of the human immunodeficiency virus. N Engl J Med 317:1125–1135

    Article  PubMed  CAS  Google Scholar 

  9. Martin LS, McDougal JS, Loskoski SL (1985) Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 152: 400–403

    Article  PubMed  CAS  Google Scholar 

  10. Spire B, Barre-Sinoussi F, Montagnier L, Chermann JC (1984) Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet: 899–901

    Google Scholar 

  11. Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD (1986) Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 255: 1887–1891

    Article  PubMed  CAS  Google Scholar 

  12. Martin LS, Loskoski SL, McDougal JS (1987) Inactivation of human T-lymphotropic virus type III/lymphadenopathy-associated virus by formaldehyde-based reagents. Appl Environ Microbiol 53: 708–709

    PubMed  CAS  Google Scholar 

  13. Kaplan JC, Crawford DC, Durno AG, Schooley RT (1987) Inactivation of human immunodeficiency virus by betadine. Infect Control 8: 412–414

    PubMed  CAS  Google Scholar 

  14. Hicks DR, Martin LS, Gretchell JP et al. (1985) Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet ii: 1422

    Article  Google Scholar 

  15. Klein RJ, Buimovici-Klein E, Ong KR, Czelusniak SM, Lange M, Friedman-Kien AE (1987) Inactivation of human immunodeficiency, herpes simplex, and vaccinia viruses by sodium oxychlorosene. Lancet ii: 281–282

    Article  Google Scholar 

  16. Prince AM, Horowitz B, Brotman B (1986) Sterilisation of hepatitis and HTLV-III viruses by exposure to Tri(n-BUTYL)phosphate and sodium cholate. Lancet 706-710

    Google Scholar 

  17. Centers for Disease Control (1985) Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 34: 681–686, 691-695

    Google Scholar 

  18. McCray E (1986) The Cooperative needlestick surveillance group. Occupational risk of the acquired immunedeficiency syndrome among health-care workers. N Engl J Med 314:1127–1132

    Article  PubMed  CAS  Google Scholar 

  19. Henderson DK, Saah AJ, Zak BJ, Kaslow RA, Lane C et al. (1986) Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med 104: 644–647

    PubMed  CAS  Google Scholar 

  20. Gerberding JL, Bryant-LeBlanc CE, Nelson K, Moss AR, Osmond D et al. (1987) Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 156:1–8

    Article  PubMed  CAS  Google Scholar 

  21. McEvoy M, Porter K, Mortimer P, Simmons N, Shanson D (1987) Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or other body fluids from patients infected with HIV. Br Med J [Clin Res] 294:1595–1597

    Article  CAS  Google Scholar 

  22. Klein RS, Phelan A, Freeman K et al. (1987) Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med 318: 86–90

    Article  Google Scholar 

  23. Anonymous (1984) Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet: 1376-1377

    Google Scholar 

  24. Oksenhendler E, Harzie M, Le Roux JM, Rabian C, Clauvel JP (1986) HIV infection with seroconversion after a superficial needlestick injury to the finger. N Engl J Med 515: 582

    Google Scholar 

  25. Neisson-Vernant C, Arfi S, Mathez D, Leibowitch J, Monplaisir N (1986) Needlestick HIV seroconversion in a nurse. Lancet 2: 814

    Article  PubMed  CAS  Google Scholar 

  26. Centers for Disease Control (1987) Update: human immunodeficiency virus infections in health care workers exposed to blood of infected patients. MMWR 36: 285–289

    Google Scholar 

  27. Centers for Disease Control (1986) Apparent transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from a child to a mother providing health care. MMWR 35: 76–79

    Google Scholar 

  28. Grint P, McEvoy M (1985) Two associated cases of the acquired immune deficiency syndrome (AIDS). PHLS Commun Dis Rep 42: 4

    Google Scholar 

  29. Weiss SH, Goedert JJ, Gartner S et al. (1988) Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science 239: 68–71

    Article  PubMed  CAS  Google Scholar 

  30. Hessol NA, Rutherford GW, O’Malley PM et al. (1987) The natural history of human immunodeficiency virus infection in a cohort of homosexual and bisexual men (Abstract). In: Abstracts from the III international conference on AIDS, June 1-5, 1987, Washington, DC, p 1

    Google Scholar 

  31. Centers for Disease Control (1986) Recommended infection-control practices for dentistry. MMWR 35: 237–242

    Google Scholar 

  32. Centers for disease control (1986) Recommendations for providing dialysis treatment to patients infected with Human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR 35: 376–383

    Google Scholar 

  33. Centers for disease control (1986) Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement. MMWR 35: 540–549

    Google Scholar 

  34. Centers for disease control (1986) Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. MMWR 35: 221–223

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Saltzman, B.R., Friedman-Kien, A.E. (1988). Inactivation of HIV and Safety Precautions for the Workplace. In: Schmid, L., Senn, HJ. (eds) AIDS-Related Neoplasias. Recent Results in Cancer Research, vol 112. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83470-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83470-7_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83472-1

  • Online ISBN: 978-3-642-83470-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics